Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | PRKCA | P17252 | 3/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24326021 | 0.75 | CYP1A2 (0.42) | CYP1A2PRKCA | |
| SCHEMBL12705146 | 0.75 | CYP1A2 (0.39) | CYP1A2PRKCA | |
| SCHEMBL686466 | 0.72 | CYP1A2 (0.35) | CYP1A2 | |
| SCHEMBL26360493 | 0.71 | CYP1A2 (0.45) | CYP1A2PRKCALMNA | |
| SCHEMBL21939485 | 0.71 | LMNA (0.50) | RECQLLMNA | |
| SCHEMBL6721695 | 0.68 | CYP1A2 (0.38) | CYP1A2 | |
| SCHEMBL21301193 | 0.68 | LMNA (0.41) | CYP1A2PRKCALMNAPOLB | |
| SCHEMBL445031 | 0.67 | ALDH1A1 (0.58) | CYP1A2PRKCA | |
| SCHEMBL26356325 | 0.67 | CYP1A2 (0.41) | CYP1A2PRKCA | |
| SCHEMBL4505131 | 0.67 | CYP1A2 (0.48) | CYP1A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-9200098-B2 | Radiation-sensitive composition and compound | JSR CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | JSR CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120164582-A1 | RADIATION-SENSITIVE COMPOSITION AND COMPOUND | RAD51, RER1, ATP6AP1 | RECQL 188/4885CYP1A2 576/4885PRKCA 1128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.